Zoetis (ZTS) Stock Price
$152.3 1.2%
to add to portfolio
AI Score
-
Alternative
6 -
Fundamental
9 -
Technical
5
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Zoetis, AI stock picks, stock alerts and much more.
ZTS AI Stock Analysis
AI stock analysis for ZTS is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Zoetis (ZTS) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Zoetis (ZTS) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Zoetis (ZTS), currently trading at $152.3, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About ZTS
-
Zoetis Inc.
-
Symbol
ZTS
-
Market
NYSE
-
Industry
Drug Manufacturers - Specialty & Generic
-
Market Cap
67.5B
Similar Stocks
 |
Elanco Animal Health ELAN |
$17.7 1.5% |
5 |
 |
Teva Pharmaceutical TEVA |
$18.06 1.1% |
5 |
News
ZTS Alternative Data
Web Traffic
Zoetis receives an estimated 347921 monthly visitors to zoetis.com.
-
Web Traffic
347921
-
Change from Previous Month
20.2%
-
3 Month Change
18.9%
-
YoY Change
18.9%
Twitter Followers
Zoetis has 16,167 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.1% over the last month.
-
Twitter Followers
16167
-
Daily Change
0%
-
1 Month Change
0.1%
-
3 Month Change
0.3%
-
YoY Change
0.3%
Facebook Engagement
Zoetis has engaged 931 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
931
-
Daily Change
9.5%
-
1 Month Change
182.1%
-
3 Month Change
201.3%
-
YoY Change
201.3%
Instagram Followers
Zoetis has 57,923 Instagram Followers on its main Instagram account, up by 0.7% over the last month.
-
Instagram Followers
57923
-
Daily Change
0%
-
1 Month Change
0.7%
-
3 Month Change
2%
-
YoY Change
2%
Youtube Subscribers
Zoetis has 6,410 subscribers on its main Youtube channel, up by 0.6% over the last month.
-
Youtube Subscribers
6410
-
Daily Change
0%
-
1 Month Change
0.6%
-
3 Month Change
1.6%
-
YoY Change
1.6%
LinkedIn Followers
532,152 are following Zoetis on LinkedIn, up by 1.7% over the last month.
-
LinkedIn Followers
532152
-
Daily Change
0%
-
1 Month Change
1.7%
-
3 Month Change
4.8%
App Downloads
-
App Downloads
20000
-
Daily Change
0%
Job Postings
Zoetis has an estimated 180 open job postings, which is down -15.9% over the last month.
-
Job Postings
180
-
Daily Change
1.6%
-
1 Month Change
15.9%
-
3 Month Change
31%
-
YoY Change
31%
LinkedIn Employees
According to LinkedIn, Zoetis has 11,651 employees, up by 0.6% over the last month.
-
LinkedIn Employees
11651
-
Daily Change
0%
-
1 Month Change
0.6%
-
3 Month Change
2.4%
-
YoY Change
2.4%
Reddit Mentions
Zoetis has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Business Outlook
According to employee reviews, the business outlook among employees at Zoetis is 70 out of 100 (bullish).
-
Business Outlook
70
-
Change from Previous Month
1.4%
-
3 Month Change
1.4%
-
YoY Change
1.4%
News Mentions
Zoetis was mentioned 3 times in the news yesterday.
-
News Mentions
3
-
Daily Change
25%
-
1 Month Change
0%
-
3 Month Change
0%
ZTS Financials
ZTS Key Metrics
-
Total Revenue
$2.3B
-
Net Income
$581M
-
Earnings per Share
$1.28
-
Free cash flow
$689M
-
EBITDA
$906M
-
EBITDA Ratio
0.391023
-
Total Assets
$14.2B
ZTS 2-year Revenue & Income
ZTS 2-year Free Cash Flow
ZTS Technicals
ZTS SMA
ZTS RSI
FAQ
What's the current price of Zoetis (ZTS) Stock?
The price of an Zoetis (ZTS) share is $152.3.
What's the market cap of Zoetis?
The current market cap of Zoetis is 67.5B.
Should I buy or sell ZTS?
Zoetis shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Zoetis is better viewed as a hold or accumulate position while waiting for further developments.
Is Zoetis a good investment?
The current analysis of Zoetis' fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Zoetis' portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Zoetis (ZTS) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Zoetis stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Zoetis (ZTS) that investors often compare it to?
Zoetis (ZTS) is often compared to similar stocks such as Elanco Animal Health and Teva Pharmaceutical.
What is the forecast for Zoetis' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Zoetis' stock price to be around $161.1 in 2026. Starting from the current price of $152.3, this represents a 5.8% change in price, indicating a bullish outlook for the stock.
How to buy Zoetis (ZTS) Stock?
Zoetis stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Zoetis shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.